Article
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels.
Annals of hematology - 1 Dec 2022
Lewandowski Krzysztof, Kanduła Zuzanna, Gniot Michał, Paczkowska Edyta, Nawrocka Paulina Maria, Wojtaszewska Marzena, Janowski Michał, Mariak Magdalena, Handschuh Luiza, Kozlowski Piotr
Abstract excerpt
It has been postulated that the changes in the molecular characteristics of the malignant clone(s) and the abnormal activation of JAK-STAT signaling are responsible for myeloproliferative neoplasm progression to more advanced disease phases and the immune escape of the malignant clone. The continuous JAK-STAT pathway activation leads to enhanced activity of the promoter of CD274 coding programmed death-1 receptor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
